Linking a cell-division gene and a suicide gene to define and improve cell therapy safety

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Genetics

Background:

• Human pluripotent cell lines offer therapeutic potential but require stringent safety measures for clinical use.
• Existing suicide gene strategies for eliminating harmful cells lack quantitative safety definitions.
• Ensuring the safety of cell-based therapies is paramount for clinical application.

Purpose of the Study:

• To develop a genome-engineered suicide system that remains active in dividing cells for enhanced cell therapy safety.
• To quantitatively assess the safety level of cell transplantation therapies using a mathematical model.
• To accelerate the clinical translation of cell-based regenerative medicine.

Main Methods:

• Genome engineering to create a transcriptional link between the herpes simplex virus thymidine kinase (HSV-TK) suicide gene and the cell-division gene CDK1.
• Development of a mathematical model to quantify cell therapy safety based on cell number and genome editing type.
• Demonstration of protection of the suicide system from inactivation in dividing cells.

Main Results:

• Successfully created a "safe-cell system" by linking HSV-TK to CDK1, ensuring suicide gene function in dividing cells.
• Developed a mathematical framework to quantitatively define the safety level of cell therapies.
• The proposed system demonstrates a significant advancement in ensuring the safety of transplanted cells.

Conclusions:

• The developed "safe-cell system" provides a robust method for enhancing the safety of human pluripotent cell-based therapies.
• Quantitative safety assessment through mathematical modeling is crucial for clinical translation.
• This approach is expected to expedite the clinical adoption of cell-based regenerative medicine.